Abstract
Background
The possibility of prostate cancer as a cause for steadily rising PSA despite previously negative transrectal ultrasound (TRUS)-guided prostate biopsies is a major concern. An initial negative TRUS-guided prostate biopsy does not necessarily exclude the presence of clinically significant prostate cancer. We determined the role of transperineal template prostate biopsy (TPTPB) in prostate cancer detection in men with raised PSA despite two previous sets of negative TRUS biopsies.
Methods
Between January 2008 and August 2012, a total of 122 men’s records were reviewed after having 36-core TPTPB following two previous sets of negative TRUS biopsies despite raised PSA. A retrospective record of PSA levels, clinicopathological parameters and histological outcomes was made.
Results
Mean age was 63 years (range 49–77), and mean PSA was 18.0 (range 2.0–119.0). A total of 71/122 (58 %) men were diagnosed with prostate cancer on TPTPB. Of these, 28 (39 %), 34 (48 %), 5 (7 %), and 4 (6 %) had Gleason score 6, 7 (3 + 4), 7 (4 + 3), and 9 (4 + 5), respectively. The mean number of positive cores was 7 (range 1–22). Of these, only 15 (21 %) had ≤2 cores positive and Gleason score of 6. Of the 51 (42 %) men with a negative histology on TPTPB, 11 (22 %), 10 (19 %), and 30 (59 %) had atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, or benign pathology.
Conclusion
TPTPB is associated with a high rate of clinically significant prostate cancer diagnosis (58 %) in men with raised PSA despite two previous sets of negative TRUS biopsies.
Similar content being viewed by others
References
Norberg M, Egevad L, Holmberg L et al (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566. doi:10.1016/S0090-4295(97)00306-3
Naughton CK, Miller DC, Mager DE et al (2000) A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164:388–392
Yuasa T, Tsuchiya N, Kumazawa T et al (2008) Characterization of prostate cancer detected at repeat biopsy. BMC Urol 8:14. doi:10.1186/1471-2490-8-14
Aganovic D, Prcic A, Kulovac B, Hadziosmanovic O (2011) Prostate cancer detection rate and the importance of premalignant lesion in rebiopsy. Med Arh 65:109–112
Stewart CS, Leibovich BC, Weaver AL, Lieber MM (2001) Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166:86–91 discussion 91–92
Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45:2–12
Fleshner N, Klotz L (2002) Role of “saturation biopsy” in the detection of prostate cancer among difficult diagnostic cases. Urology 60:93–97
Walz J, Graefen M, Chun FKH et al (2006) High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50:498–505. doi:10.1016/j.eururo.2006.03.026
Jones JS, Patel A, Schoenfield L et al (2006) Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 175:485–488. doi:10.1016/S0022-5347(05)00211-9
Pal RP, Elmussareh M, Chanawani M, Khan MA (2012) The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies. BJU Int 109:367–371. doi:10.1111/j.1464-410X.2011.10355.x
Carter HB, Pearson JD, Metter EJ et al (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215–2220
Connolly D, Black A, Murray LJ et al (2007) Methods of calculating prostate-specific antigen velocity. Eur Urol 52:1044–1051. doi:10.1016/j.eururo.2006.12.017
Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74 Discussion 74–75
Shariat SF, Semjonow A, Lilja H et al (2011) Tumor markers in prostate cancer I: blood-based markers. Acta Oncol 50(Suppl 1):61–75. doi:10.3109/0284186X.2010.542174
Djavan B, Ravery V, Zlotta A et al (2001) Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166:1679–1683
Taira AV, Merrick GS, Galbreath RW et al (2009) Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 13:71–77. doi:10.1038/pcan.2009.42
Bittner N, Merrick GS, Andreini H et al (2009) Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB. Urology 74:171–176. doi:10.1016/j.urology.2008.12.013
Bott SRJ, Henderson A, Halls JE et al (2006) Extensive transperineal template biopsies of prostate: modified technique and results. Urology 68:1037–1041. doi:10.1016/j.urology.2006.05.033
Mabjeesh NJ, Lidawi G, Chen J et al (2012) High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int 110:993–997. doi:10.1111/j.1464-410X.2012.10972.x
Dimmen M, Vlatkovic L, Hole KH et al (2012) Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int 110:E69–E75. doi:10.1111/j.1464-410X.2011.10759.x
D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974. doi:10.1001/jama.280.11.969
Emiliozzi P, Longhi S, Scarpone P et al (2001) The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen. J Urol 166:845–850
Bittner N, Merrick GS, Butler WM et al (2013) Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol 190:509–514. doi:10.1016/j.juro.2013.02.021
Pinkstaff DM, Igel TC, Petrou SP et al (2005) Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 65:735–739. doi:10.1016/j.urology.2004.10.067
Ekwueme K, Simpson H, Zakhour H, Parr NJ (2013) Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int 111:E365–E373. doi:10.1111/bju.12134
Pepe P, Aragona F (2013) Prostate biopsy: results and advantages of the transperineal approach—twenty-year experience of a single center. World J Urol. doi:10.1007/s00345-013-1108-1
Epstein JI, Sanderson H, Carter HB, Scharfstein DO (2005) Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 66:356–360. doi:10.1016/j.urology.2005.03.002
Hossack T, Patel MI, Huo A et al (2012) Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 188:781–785. doi:10.1016/j.juro.2012.05.006
Conflict of interest
Authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nafie, S., Pal, R.P., Dormer, J.P. et al. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies. World J Urol 32, 971–975 (2014). https://doi.org/10.1007/s00345-013-1225-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1225-x